Developing vaccines against foot-and-mouth disease and some other exotic viral diseases of livestock
暂无分享,去创建一个
[1] Zhidong Zhang,et al. Foot-and-Mouth Disease Virus Persists in the Light Zone of Germinal Centres , 2008, PloS one.
[2] B. Chomel,et al. Risques d’introduction et d’implantation en Europe de maladies infectieuses exotiques , 2009 .
[3] J. Lubroth,et al. Experience with eradicating rinderpest by vaccination. , 2004, Developments in biologicals.
[4] S. Reid,et al. Interferon-gamma production in vitro from whole blood of foot-and-mouth disease virus (FMDV) vaccinated and infected cattle after incubation with inactivated FMDV. , 2006, Vaccine.
[5] K. Karaca,et al. Recombinant canarypox virus vaccine co-expressing genes encoding the VP2 and VP5 outer capsid proteins of bluetongue virus induces high level protection in sheep. , 2007, Vaccine.
[6] J. Wilesmith,et al. Modelling studies to estimate the prevalence of foot-and-mouth disease carriers after reactive vaccination , 2008, Proceedings of the Royal Society B: Biological Sciences.
[7] R. Singh,et al. The current status of sheep pox disease. , 2006, Comparative immunology, microbiology and infectious diseases.
[8] S. Zanker,et al. Animal vaccination and the veterinary pharmaceutical industry. , 2007, Revue scientifique et technique.
[9] J. Suzich,et al. Baculovirus expression of the M genome segment of Rift Valley fever virus and examination of antigenic and immunogenic properties of the expressed proteins. , 1989, Virology.
[10] P. Roy,et al. Bluetongue vaccines. , 2009, Vaccine.
[11] S. Barros,et al. A DIVA system based on the detection of antibodies to non-structural protein 3 (NS3) of bluetongue virus. , 2009, Veterinary microbiology.
[12] C. Batten,et al. Global distribution of peste des petits ruminants virus and prospects for improved diagnosis and control. , 2010, The Journal of general virology.
[13] P. Roy,et al. Development of Reverse Genetics Systems for Bluetongue Virus: Recovery of Infectious Virus from Synthetic RNA Transcripts , 2008, Journal of Virology.
[14] P. Mellor,et al. Viraemia and clinical disease in Dorset Poll sheep following vaccination with live attenuated bluetongue virus vaccines serotypes 16 and 4. , 2010, Vaccine.
[15] M. Lombard,et al. Antigen and vaccine banks: technical requirements and the role of the european antigen bank in emergency foot and mouth disease vaccination. , 2007, Revue scientifique et technique.
[16] P. Mertens,et al. A competitive ELISA for the detection of anti-tubule antibodies using a monoclonal antibody against bluetongue virus non-structural protein NS1. , 1993, Journal of virological methods.
[17] Zhiyong Li,et al. FMD subunit vaccine produced using a silkworm-baculovirus expression system: protective efficacy against two type Asia1 isolates in cattle. , 2011, Veterinary microbiology.
[18] F. Maree,et al. Custom-engineered chimeric foot-and-mouth disease vaccine elicits protective immune responses in pigs. , 2011, The Journal of general virology.
[19] M. Bouloy,et al. Rift Valley fever virus (Bunyaviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention , 2010, Veterinary research.
[20] M. Sinclair,et al. Qualitative assessment of the commodity risk for spread of foot-and-mouth disease associated with international trade in deboned beef. , 2010, Transboundary and emerging diseases.
[21] M. Jeggo,et al. A study of the role of cell-mediated immunity in bluetongue virus infection in sheep, using cellular adoptive transfer techniques. , 1984, Immunology.
[22] B. Coupar,et al. Antibody responses and protective immunity to recombinant vaccinia virus-expressed bluetongue virus antigens. , 1997, Veterinary immunology and immunopathology.
[23] E. Domingo,et al. Foot-and-mouth disease virus. , 2002, Comparative immunology, microbiology and infectious diseases.
[24] J. Sánchez-Vizcaíno,et al. Vaccines against bluetongue in Europe. , 2008, Comparative immunology, microbiology and infectious diseases.
[25] S. Gubbins,et al. Foot-and-Mouth Disease Virus Can Induce a Specific and Rapid CD4+ T-Cell-Independent Neutralizing and Isotype Class-Switched Antibody Response in Naïve Cattle , 2009, Journal of Virology.
[26] M. Jeggo,et al. Importance of ovine cytotoxic T cells in protection against bluetongue virus infection. , 1985, Progress in clinical and biological research.
[27] G. Nabel,et al. Induction of Broadly Neutralizing H1N1 Influenza Antibodies by Vaccination , 2010, Science.
[28] E. Domingo,et al. A large-scale evaluation of peptide vaccines against foot-and-mouth disease: lack of solid protection in cattle and isolation of escape mutants , 1997, Journal of virology.
[29] D. Paton,et al. Strategies for differentiating infection in vaccinated animals (DIVA) for foot-and-mouth disease, classical swine fever and avian influenza , 2010, Expert review of vaccines.
[30] H. R. Cox. BLUETONGUE , 1954, CABI Compendium.
[31] J. Valarcher,et al. Selection of foot and mouth disease vaccine strains--a review. , 2005, Revue scientifique et technique.
[32] J. Y. Scheerlinck,et al. Genetic adjuvants for DNA vaccines. , 2001, Vaccine.
[33] H. Takamatsu,et al. In vivo depletion of CD8+ T lymphocytes abrogates protective immunity to African swine fever virus. , 2005, The Journal of general virology.
[34] H. Thulke,et al. High potency vaccines induce protection against heterologous challenge with foot-and-mouth disease virus. , 2008, Vaccine.
[35] L. Dixon,et al. African swine fever: how can global spread be prevented? , 2009, Philosophical Transactions of the Royal Society B: Biological Sciences.
[36] P. Roy,et al. Rift Valley fever virus structural proteins: expression, characterization and assembly of recombinant proteins , 2008, Virology Journal.
[37] B. Charleston,et al. Global FMD control--is it an option? , 2007, Vaccine.
[38] P. Mellor,et al. Expression of the major core structural protein (VP7) of bluetongue virus, by a recombinant capripox virus, provides partial protection of sheep against a virulent heterotypic bluetongue virus challenge. , 1996, Virology.
[39] M. Greiner,et al. Application of non-structural protein antibody tests in substantiating freedom from foot-and-mouth disease virus infection after emergency vaccination of cattle. , 2006, Vaccine.
[40] M. Grubman. Development of novel strategies to control foot-and-mouth disease: marker vaccines and antivirals. , 2005, Biologicals : journal of the International Association of Biological Standardization.
[41] T. Barrett,et al. Matrix protein and glycoproteins F and H of Peste-des-petits-ruminants virus function better as a homologous complex. , 2006, The Journal of general virology.
[42] R. May,et al. Modelling vaccination strategies against foot-and-mouth disease , 2003, Nature.
[43] Kehe Huang,et al. A goat poxvirus-vectored peste-des-petits-ruminants vaccine induces long-lasting neutralization antibody to high levels in goats and sheep. , 2010, Vaccine.
[44] B. Charleston,et al. Options for control of foot-and-mouth disease: knowledge, capability and policy , 2009, Philosophical Transactions of the Royal Society B: Biological Sciences.
[45] R. Parkhouse,et al. The non-haemadsorbing African swine fever virus isolate ASFV/NH/P68 provides a model for defining the protective anti-virus immune response. , 2001, The Journal of general virology.
[46] M. Heise,et al. An alphavirus replicon-derived candidate vaccine against Rift Valley fever virus , 2009, Epidemiology and Infection.
[47] P. Roy,et al. Validation of a novel approach for the rapid production of immunogenic virus-like particles for bluetongue virus. , 2010, Vaccine.
[48] T. Barrett,et al. Cell-mediated immune responses in cattle vaccinated with a vaccinia virus recombinant expressing the nucleocapsid protein of rinderpest virus. , 1999, The Journal of general virology.
[49] G. Gerbier,et al. Review of the status of foot and mouth disease and approach to control/eradication in Europe and Central Asia. , 2002, Revue scientifique et technique.
[50] T. Barrett,et al. Rescue of a chimeric rinderpest virus with the nucleocapsid protein derived from peste-des-petits-ruminants virus: use as a marker vaccine , 2007, The Journal of general virology.
[51] Camille Szmaragd,et al. The Spread of Bluetongue Virus Serotype 8 in Great Britain and Its Control by Vaccination , 2010, PloS one.
[52] G. Thomson,et al. Certification for regional and international trade in livestock commodities: the need to balance credibility and enterprise , 2006, Veterinary Record.
[53] T. Barrett,et al. The threat of peste des petits ruminants: progress in vaccine development for disease control. , 2007, Vaccine.
[54] F. Roger,et al. Avian influenza vaccines: a practical review in relation to their application in the field with a focus on the Asian experience , 2008, Epidemiology and Infection.
[55] V. Saraiva,et al. Review of the status of foot and mouth disease in countries of South America and approaches to control and eradication. , 2002, Revue scientifique et technique.
[56] K. McCullough,et al. Protective immune response against foot-and-mouth disease , 1992, Journal of virology.
[57] M. Habjan,et al. Vaccination with virus-like particles protects mice from lethal infection of Rift Valley Fever Virus. , 2009, Virology.
[58] G. Viljoen,et al. Protective immune responses induced by different recombinant vaccine regimes to Rift Valley fever. , 2006, Vaccine.
[59] T. Ksiazek,et al. Rift Valley fever virus. , 2009, Journal of the American Veterinary Medical Association.
[60] G. Nabel,et al. Enhanced Breadth of CD4 T-Cell Immunity by DNA Prime and Adenovirus Boost Immunization to Human Immunodeficiency Virus Env and Gag Immunogens , 2005, Journal of Virology.
[61] H. Siegismund,et al. Low diversity of foot-and-mouth disease serotype C virus in Kenya: evidence for probable vaccine strain re-introductions in the field , 2010, Epidemiology and Infection.
[62] Zhiyong Li,et al. The current state of vaccines used in the field for foot and mouth disease virus in China , 2011, Expert review of vaccines.
[63] T. Ksiazek,et al. Rift Valley Fever Virus Lacking the NSs and NSm Genes Is Highly Attenuated, Confers Protective Immunity from Virulent Virus Challenge, and Allows for Differential Identification of Infected and Vaccinated Animals , 2008, Journal of Virology.
[64] Yanmin Li,et al. Dramatic improvement in FMD DNA vaccine efficacy and cross-serotype antibody induction in pigs following a protein boost. , 2008, Vaccine.